Efforts to substitute the despicable practice of animal testing are not new in India. Bharatnatyam dancer and animal rights activist, the late Rukmini Devi Arundale, as a private member of the Rajya Sabha introduced a Bill in 1952 for the prevention of cruelty to animals. To her credit, the Bill was enacted in 1960. In 2012, after being prevailed upon by PETA, the Ministry of Environment and Forests issued guidelines to the University Grants Commission (UGC) to replace dissection and experimentation on animals for training purposes in undergraduate and postgraduate courses with computer-aided learning and simulators. In 2014, the UGC, on the intervention of PETA and Maneka Gandhi, ensured full compliance with the guidelines. PETA is now offering a free virtual frog dissection software to schools and colleges.
On the subject of pharmaceutical testing on animals, a more vicious practice, I would like to draw the attention of companies to an innovative alternative called CytoSolve devised by V Shiva Ayyadurai, a US-based scientist of Indian origin. CytoSolve is an in-silico (computer-based) drug discovery tool that can simulate diseases such as cancer, diabetes, fibrosis, inflammation etc on a computer. It can model even complex cellular functions of the human body, obviating the need for animal testing. Ayyadurai has drawn inspiration for his computational tool from Siddha, the holistic Indian system of medicine.
Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201
E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
